Danish educational materials

02 February 2023

From November 15th 2016 the Danish Medicines Agency published Danish educational materials for human medicinal products approved via the national procedure, the mutual recognition procedure and the decentralised procedure.

From January 1st 2023 and forward – and not retroactively - the Danish Medicines Agency also publishes Danish educational materials for human medicinal products approved via the centralised procedure.

The marketing authorisation holder has the overall responsibility for the educational material and for ensuring that it complies with the conditions of the marketing authorisation. The marketing authorisation holder also has the overall responsibility for ensuring that the Danish Medicines Agency has the latest accepted written educational material available for publication.

Please refer to the section Dansk uddannelsesmateriale for the accepted and published Danish educational materials 

Name Medicine Type Strength Active substance Mft owner Publish Date
Abacavir/Lamivudin "Mylan" filmovertrukne tabletter 600+300 mg Abacavirhydrochlorid, LAMIVUDIN Mylan AB 18/12/2017
Abacavir/Lamivudine "Sandoz" filmovertrukne tabletter 600+300 mg Abacavirhydrochlorid, LAMIVUDIN Sandoz A/S 09/02/2018
Abstral resoribletter, sublinguale 100 mikrogram FENTANYLCITRAT Kyowa Kirin Holdings B.V. 28/08/2019
Abstral resoribletter, sublinguale 200 mikrogram FENTANYLCITRAT Kyowa Kirin Holdings B.V. 28/08/2019
Abstral resoribletter, sublinguale 300 mikrogram FENTANYLCITRAT Kyowa Kirin Holdings B.V. 28/08/2019
Abstral resoribletter, sublinguale 400 mikrogram FENTANYLCITRAT Kyowa Kirin Holdings B.V. 28/08/2019
Abstral resoribletter, sublinguale 600 mikrogram FENTANYLCITRAT Kyowa Kirin Holdings B.V. 28/08/2019
Abstral resoribletter, sublinguale 800 mikrogram FENTANYLCITRAT Kyowa Kirin Holdings B.V. 28/08/2019
Acitretin "Orifarm" kapsler, hårde 10 mg ACITRETIN Orifarm Generics A/S 26/09/2018
Acitretin "Orifarm" kapsler, hårde 25 mg ACITRETIN Orifarm Generics A/S 26/09/2018
Actiq sugetabletter 200 mikrogram FENTANYLCITRAT Teva Pharma B.V. 26/05/2023
Actiq sugetabletter 400 mikrogram FENTANYLCITRAT Teva Pharma B.V. 26/05/2023
Actiq sugetabletter 600 mikrogram FENTANYLCITRAT Teva Pharma B.V. 26/05/2023
Actiq sugetabletter 800 mikrogram FENTANYLCITRAT Teva Pharma B.V. 26/05/2023
Aduvanz kapsler, hårde 30 mg Lisdexamfetamindimesilat Takeda Pharmaceuticals International AG Ireland Branch 15/08/2023
Aduvanz kapsler, hårde 50 mg Lisdexamfetamindimesilat Takeda Pharmaceuticals International AG Ireland Branch 15/08/2023
Aduvanz kapsler, hårde 70 mg Lisdexamfetamindimesilat Takeda Pharmaceuticals International AG Ireland Branch 15/08/2023
Aduvanz kapsler, hårde 40 mg Lisdexamfetamindimesilat Takeda Pharmaceuticals International AG Ireland Branch 15/08/2023
Aduvanz kapsler, hårde 20 mg Lisdexamfetamindimesilat Takeda Pharmaceuticals International AG Ireland Branch 15/08/2023
Aduvanz kapsler, hårde 60 mg Lisdexamfetamindimesilat Takeda Pharmaceuticals International AG Ireland Branch 15/08/2023